Skip to main content Skip to main navigation Skip to search Skip to footer

HCL Technologies

Endo Pharmaceuticals Implements Open Innovation Network With HCL and Other R&D Partners

Endo Pharmaceuticals Implements Open Innovation Network With HCL and Other R&D Partners

In an effort to diversify its product portfolio, Endo Pharmaceuticals quickly realized that it no longer could rely solely on a static R&D infrastructure to achieve its goals. It needed a cost-effective, scalable and agile innovation network built on value-based partnerships.

DOWNLOAD THE SUCCESS STORY

Contact Us
MAX CHARACTERS: 10,000

We will treat any information you submit with us as confidential.

We will treat any information you submit with us as confidential.